1Q41 - Header Asymmetric Unit

HEADER TRANSFERASE 01-AUG-03 1Q41

TITLE GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'-MONOXIME

COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GSK-3 BETA; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSK3B; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: H5; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PVL-GST-GSK3BETA

KEYWDS KINASE, INSULIN PATHWAY, INDIRUBIN-3'-MONOXIME, TRANSFERASE

EXPDTA X-RAY DIFFRACTION

AUTHOR J.A.BERTRAND,S.THIEFFINE,A.VULPETTI,C.CRISTIANI,B.VALSASINA, AUTHOR 2 S.KNAPP,H.M.KALISZ,M.FLOCCO

REVDAT 2 24-FEB-09 1Q41 1 VERSN REVDAT 1 21-OCT-03 1Q41 0

JRNL AUTH J.A.BERTRAND,S.THIEFFINE,A.VULPETTI,C.CRISTIANI, JRNL AUTH 2 B.VALSASINA,S.KNAPP,H.M.KALISZ,M.FLOCCO JRNL TITL STRUCTURAL CHARACTERIZATION OF THE GSK-3BETA JRNL TITL 2 ACTIVE SITE USING SELECTIVE AND NON-SELECTIVE JRNL TITL 3 ATP-MIMETIC INHIBITORS JRNL REF J.MOL.BIOL. V. 333 393 2003 JRNL REFN ISSN 0022-2836 JRNL PMID 14529625 JRNL DOI 10.1016/J.JMB.2003.08.031

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2340596.150 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 76076 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3844 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 11841 REMARK 3 BIN R VALUE (WORKING SET) : 0.2960 REMARK 3 BIN FREE R VALUE : 0.3190 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 684 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5428 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 147 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.21000 REMARK 3 B22 (A**2) : 14.60000 REMARK 3 B33 (A**2) : -17.81000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.29 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.29 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.50 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.00 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.560 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.540 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.160 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.280 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 50.40 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1Q41 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-AUG-03. REMARK 100 THE RCSB ID CODE IS RCSB019888.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUL-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 76152 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.390 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.3325 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.42300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.592 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1H8F REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350 MONODISPERSE, GLYCEROL, REMARK 280 MAGNESIUM CHLORIDE, HEPES, PH 7.00, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.71900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 89.41250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.22150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 89.41250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.71900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.22150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 PRO A -2 REMARK 465 LEU A -1 REMARK 465 GLY A 0 REMARK 465 SER A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 ARG A 4 REMARK 465 PRO A 5 REMARK 465 ARG A 6 REMARK 465 THR A 7 REMARK 465 THR A 8 REMARK 465 SER A 9 REMARK 465 PHE A 10 REMARK 465 ALA A 11 REMARK 465 GLU A 12 REMARK 465 SER A 13 REMARK 465 CYS A 14 REMARK 465 LYS A 15 REMARK 465 PRO A 16 REMARK 465 VAL A 17 REMARK 465 GLN A 18 REMARK 465 GLN A 19 REMARK 465 PRO A 20 REMARK 465 SER A 21 REMARK 465 ALA A 22 REMARK 465 PHE A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 MET A 26 REMARK 465 LYS A 27 REMARK 465 VAL A 28 REMARK 465 SER A 29 REMARK 465 ARG A 30 REMARK 465 ASP A 31 REMARK 465 LYS A 32 REMARK 465 ASP A 33 REMARK 465 GLY A 34 REMARK 465 GLY A 120 REMARK 465 GLU A 121 REMARK 465 LYS A 122 REMARK 465 LYS A 123 REMARK 465 ASP A 124 REMARK 465 GLU A 125 REMARK 465 ASN A 285 REMARK 465 PRO A 286 REMARK 465 ASN A 287 REMARK 465 TYR A 288 REMARK 465 THR A 289 REMARK 465 GLU A 290 REMARK 465 PHE A 291 REMARK 465 ALA A 387 REMARK 465 ALA A 388 REMARK 465 SER A 389 REMARK 465 THR A 390 REMARK 465 PRO A 391 REMARK 465 THR A 392 REMARK 465 ASN A 393 REMARK 465 ALA A 394 REMARK 465 THR A 395 REMARK 465 ALA A 396 REMARK 465 ALA A 397 REMARK 465 SER A 398 REMARK 465 ASP A 399 REMARK 465 ALA A 400 REMARK 465 ASN A 401 REMARK 465 THR A 402 REMARK 465 GLY A 403 REMARK 465 ASP A 404 REMARK 465 ARG A 405 REMARK 465 GLY A 406 REMARK 465 GLN A 407 REMARK 465 THR A 408 REMARK 465 ASN A 409 REMARK 465 ASN A 410 REMARK 465 ALA A 411 REMARK 465 ALA A 412 REMARK 465 SER A 413 REMARK 465 ALA A 414 REMARK 465 SER A 415 REMARK 465 ALA A 416 REMARK 465 SER A 417 REMARK 465 ASN A 418 REMARK 465 SER A 419 REMARK 465 THR A 420 REMARK 465 GLY B -3 REMARK 465 PRO B -2 REMARK 465 LEU B -1 REMARK 465 GLY B 0 REMARK 465 SER B 1 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 ARG B 4 REMARK 465 PRO B 5 REMARK 465 ARG B 6 REMARK 465 THR B 7 REMARK 465 THR B 8 REMARK 465 SER B 9 REMARK 465 PHE B 10 REMARK 465 ALA B 11 REMARK 465 GLU B 12 REMARK 465 SER B 13 REMARK 465 CYS B 14 REMARK 465 LYS B 15 REMARK 465 PRO B 16 REMARK 465 VAL B 17 REMARK 465 GLN B 18 REMARK 465 GLN B 19 REMARK 465 PRO B 20 REMARK 465 SER B 21 REMARK 465 ALA B 22 REMARK 465 PHE B 23 REMARK 465 GLY B 24 REMARK 465 SER B 25 REMARK 465 MET B 26 REMARK 465 LYS B 27 REMARK 465 VAL B 28 REMARK 465 SER B 29 REMARK 465 ARG B 30 REMARK 465 ASP B 31 REMARK 465 LYS B 32 REMARK 465 ASP B 33 REMARK 465 GLY B 34 REMARK 465 GLY B 120 REMARK 465 GLU B 121 REMARK 465 LYS B 122 REMARK 465 LYS B 123 REMARK 465 ASP B 124 REMARK 465 GLU B 125 REMARK 465 ILE B 384 REMARK 465 GLN B 385 REMARK 465 ALA B 386 REMARK 465 ALA B 387 REMARK 465 ALA B 388 REMARK 465 SER B 389 REMARK 465 THR B 390 REMARK 465 PRO B 391 REMARK 465 THR B 392 REMARK 465 ASN B 393 REMARK 465 ALA B 394 REMARK 465 THR B 395 REMARK 465 ALA B 396 REMARK 465 ALA B 397 REMARK 465 SER B 398 REMARK 465 ASP B 399 REMARK 465 ALA B 400 REMARK 465 ASN B 401 REMARK 465 THR B 402 REMARK 465 GLY B 403 REMARK 465 ASP B 404 REMARK 465 ARG B 405 REMARK 465 GLY B 406 REMARK 465 GLN B 407 REMARK 465 THR B 408 REMARK 465 ASN B 409 REMARK 465 ASN B 410 REMARK 465 ALA B 411 REMARK 465 ALA B 412 REMARK 465 SER B 413 REMARK 465 ALA B 414 REMARK 465 SER B 415 REMARK 465 ALA B 416 REMARK 465 SER B 417 REMARK 465 ASN B 418 REMARK 465 SER B 419 REMARK 465 THR B 420

REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 90 CB CG OD1 OD2 REMARK 470 ARG A 92 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 292 CG CD CE NZ REMARK 470 ASP B 90 CB CG OD1 OD2 REMARK 470 ARG B 92 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 292 CG CD CE NZ

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 77 -81.04 -55.17 REMARK 500 ASP A 181 49.27 -147.15 REMARK 500 ASP A 200 85.31 63.36 REMARK 500 CYS A 218 135.13 80.34 REMARK 500 ARG A 220 -78.26 -13.64 REMARK 500 PHE A 229 0.85 -69.97 REMARK 500 GLN A 295 61.81 -66.41 REMARK 500 PRO A 300 99.10 -52.48 REMARK 500 TRP A 301 -27.73 -37.14 REMARK 500 ARG A 308 4.67 87.06 REMARK 500 ASN A 370 72.49 -176.68 REMARK 500 ASN B 64 -120.91 -128.12 REMARK 500 ASP B 77 -87.08 -56.69 REMARK 500 ASP B 181 47.81 -150.50 REMARK 500 ASP B 200 85.88 62.59 REMARK 500 CYS B 218 130.54 82.35 REMARK 500 ARG B 220 -84.50 -11.43 REMARK 500 ASN B 287 51.16 -105.19 REMARK 500 GLU B 290 119.03 89.53 REMARK 500 ALA B 298 123.87 -23.84 REMARK 500 ASN B 370 72.49 -178.62 REMARK 500 REMARK 500 REMARK: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IXM A 451 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IXM B 452

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PYX RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH ANP REMARK 900 RELATED ID: 1Q3D RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH STAUROSPORINE REMARK 900 RELATED ID: 1Q3W RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE REMARK 900 RELATED ID: 1Q4L RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH I-5

DBREF 1Q41 A 2 420 UNP P49841 GSK3B_HUMAN 2 420 DBREF 1Q41 B 2 420 UNP P49841 GSK3B_HUMAN 2 420

SEQADV 1Q41 GLY A -3 UNP P49841 CLONING ARTIFACT SEQADV 1Q41 PRO A -2 UNP P49841 CLONING ARTIFACT SEQADV 1Q41 LEU A -1 UNP P49841 CLONING ARTIFACT SEQADV 1Q41 GLY A 0 UNP P49841 CLONING ARTIFACT SEQADV 1Q41 SER A 1 UNP P49841 CLONING ARTIFACT SEQADV 1Q41 GLY B -3 UNP P49841 CLONING ARTIFACT SEQADV 1Q41 PRO B -2 UNP P49841 CLONING ARTIFACT SEQADV 1Q41 LEU B -1 UNP P49841 CLONING ARTIFACT SEQADV 1Q41 GLY B 0 UNP P49841 CLONING ARTIFACT SEQADV 1Q41 SER B 1 UNP P49841 CLONING ARTIFACT

SEQRES 1 A 424 GLY PRO LEU GLY SER SER GLY ARG PRO ARG THR THR SER SEQRES 2 A 424 PHE ALA GLU SER CYS LYS PRO VAL GLN GLN PRO SER ALA SEQRES 3 A 424 PHE GLY SER MET LYS VAL SER ARG ASP LYS ASP GLY SER SEQRES 4 A 424 LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN GLY PRO SEQRES 5 A 424 ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR LYS VAL SEQRES 6 A 424 ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN ALA LYS SEQRES 7 A 424 LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS LYS VAL SEQRES 8 A 424 LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU GLN ILE SEQRES 9 A 424 MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG LEU ARG SEQRES 10 A 424 TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP GLU VAL SEQRES 11 A 424 TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU THR VAL SEQRES 12 A 424 TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS GLN THR SEQRES 13 A 424 LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR GLN LEU SEQRES 14 A 424 PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY ILE CYS SEQRES 15 A 424 HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU ASP PRO SEQRES 16 A 424 ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY SER ALA SEQRES 17 A 424 LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER TYR ILE SEQRES 18 A 424 CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE PHE GLY SEQRES 19 A 424 ALA THR ASP TYR THR SER SER ILE ASP VAL TRP SER ALA SEQRES 20 A 424 GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN PRO ILE SEQRES 21 A 424 PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL GLU ILE SEQRES 22 A 424 ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN ILE ARG SEQRES 23 A 424 GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE PRO GLN SEQRES 24 A 424 ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG PRO ARG SEQRES 25 A 424 THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG LEU LEU SEQRES 26 A 424 GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU GLU ALA SEQRES 27 A 424 CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP PRO ASN SEQRES 28 A 424 VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA LEU PHE SEQRES 29 A 424 ASN PHE THR THR GLN GLU LEU SER SER ASN PRO PRO LEU SEQRES 30 A 424 ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE GLN ALA SEQRES 31 A 424 ALA ALA SER THR PRO THR ASN ALA THR ALA ALA SER ASP SEQRES 32 A 424 ALA ASN THR GLY ASP ARG GLY GLN THR ASN ASN ALA ALA SEQRES 33 A 424 SER ALA SER ALA SER ASN SER THR SEQRES 1 B 424 GLY PRO LEU GLY SER SER GLY ARG PRO ARG THR THR SER SEQRES 2 B 424 PHE ALA GLU SER CYS LYS PRO VAL GLN GLN PRO SER ALA SEQRES 3 B 424 PHE GLY SER MET LYS VAL SER ARG ASP LYS ASP GLY SER SEQRES 4 B 424 LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN GLY PRO SEQRES 5 B 424 ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR LYS VAL SEQRES 6 B 424 ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN ALA LYS SEQRES 7 B 424 LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS LYS VAL SEQRES 8 B 424 LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU GLN ILE SEQRES 9 B 424 MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG LEU ARG SEQRES 10 B 424 TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP GLU VAL SEQRES 11 B 424 TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU THR VAL SEQRES 12 B 424 TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS GLN THR SEQRES 13 B 424 LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR GLN LEU SEQRES 14 B 424 PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY ILE CYS SEQRES 15 B 424 HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU ASP PRO SEQRES 16 B 424 ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY SER ALA SEQRES 17 B 424 LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER TYR ILE SEQRES 18 B 424 CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE PHE GLY SEQRES 19 B 424 ALA THR ASP TYR THR SER SER ILE ASP VAL TRP SER ALA SEQRES 20 B 424 GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN PRO ILE SEQRES 21 B 424 PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL GLU ILE SEQRES 22 B 424 ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN ILE ARG SEQRES 23 B 424 GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE PRO GLN SEQRES 24 B 424 ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG PRO ARG SEQRES 25 B 424 THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG LEU LEU SEQRES 26 B 424 GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU GLU ALA SEQRES 27 B 424 CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP PRO ASN SEQRES 28 B 424 VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA LEU PHE SEQRES 29 B 424 ASN PHE THR THR GLN GLU LEU SER SER ASN PRO PRO LEU SEQRES 30 B 424 ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE GLN ALA SEQRES 31 B 424 ALA ALA SER THR PRO THR ASN ALA THR ALA ALA SER ASP SEQRES 32 B 424 ALA ASN THR GLY ASP ARG GLY GLN THR ASN ASN ALA ALA SEQRES 33 B 424 SER ALA SER ALA SER ASN SER THR

HET IXM A 451 21 HET IXM B 452 21

HETNAM IXM (Z)-1H,1'H-[2,3']BIINDOLYLIDENE-3,2'-DIONE-3-OXIME

HETSYN IXM INDIRUBIN-3'-MONOXIME

FORMUL 3 IXM 2(C16 H11 N3 O2) FORMUL 5 HOH *147(H2 O)

HELIX 1 1 ASN A 95 LYS A 103 1 9 HELIX 2 2 VAL A 139 ARG A 148 1 10 HELIX 3 3 PRO A 154 SER A 174 1 21 HELIX 4 4 LYS A 183 GLN A 185 5 3 HELIX 5 5 SER A 219 ARG A 223 5 5 HELIX 6 6 ALA A 224 PHE A 229 1 6 HELIX 7 7 SER A 236 GLY A 253 1 18 HELIX 8 8 SER A 261 GLY A 274 1 14 HELIX 9 9 THR A 277 MET A 284 1 8 HELIX 10 10 PRO A 300 PHE A 305 1 6 HELIX 11 11 PRO A 310 LEU A 321 1 12 HELIX 12 12 THR A 324 ARG A 328 5 5 HELIX 13 13 THR A 330 ALA A 336 1 7 HELIX 14 14 HIS A 337 ASP A 345 5 9 HELIX 15 15 THR A 363 SER A 368 1 6 HELIX 16 16 ASN A 370 PRO A 372 5 3 HELIX 17 17 LEU A 373 ILE A 378 1 6 HELIX 18 18 PRO A 379 ILE A 384 5 6 HELIX 19 19 ASN B 95 LEU B 104 1 10 HELIX 20 20 VAL B 139 ARG B 148 1 10 HELIX 21 21 PRO B 154 SER B 174 1 21 HELIX 22 22 LYS B 183 GLN B 185 5 3 HELIX 23 23 SER B 219 ARG B 223 5 5 HELIX 24 24 ALA B 224 PHE B 229 1 6 HELIX 25 25 SER B 236 GLY B 253 1 18 HELIX 26 26 SER B 261 GLY B 274 1 14 HELIX 27 27 THR B 277 ASN B 285 1 9 HELIX 28 28 PRO B 300 VAL B 304 5 5 HELIX 29 29 PRO B 310 LEU B 321 1 12 HELIX 30 30 THR B 324 ARG B 328 5 5 HELIX 31 31 THR B 330 ALA B 336 1 7 HELIX 32 32 HIS B 337 ASP B 345 5 9 HELIX 33 33 THR B 363 SER B 368 1 6 HELIX 34 34 ASN B 370 PRO B 372 5 3 HELIX 35 35 LEU B 373 ILE B 378 1 6

SHEET 1 A 7 THR A 38 PRO A 44 0 SHEET 2 A 7 GLN A 52 GLY A 63 -1 O GLN A 52 N ALA A 42 SHEET 3 A 7 VAL A 70 LEU A 75 -1 O LYS A 74 N THR A 57 SHEET 4 A 7 LEU A 81 LEU A 88 -1 O ILE A 84 N TYR A 71 SHEET 5 A 7 TYR A 127 ASP A 133 -1 O LEU A 132 N ALA A 83 SHEET 6 A 7 LEU A 112 SER A 118 -1 N SER A 118 O TYR A 127 SHEET 7 A 7 THR A 38 PRO A 44 -1 N THR A 43 O PHE A 115 SHEET 1 B 3 GLU A 137 THR A 138 0 SHEET 2 B 3 LEU A 187 LEU A 189 -1 O LEU A 189 N GLU A 137 SHEET 3 B 3 LEU A 196 LEU A 198 -1 O LYS A 197 N LEU A 188 SHEET 1 C 2 ILE A 177 CYS A 178 0 SHEET 2 C 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178 SHEET 1 D 7 THR B 38 PRO B 44 0 SHEET 2 D 7 GLN B 52 GLY B 63 -1 O VAL B 54 N VAL B 40 SHEET 3 D 7 VAL B 69 LEU B 75 -1 O LYS B 74 N THR B 57 SHEET 4 D 7 LEU B 81 LEU B 88 -1 O LYS B 86 N VAL B 69 SHEET 5 D 7 TYR B 127 ASP B 133 -1 O LEU B 132 N ALA B 83 SHEET 6 D 7 LEU B 112 SER B 118 -1 N SER B 118 O TYR B 127 SHEET 7 D 7 THR B 38 PRO B 44 -1 N THR B 43 O PHE B 115 SHEET 1 E 3 GLU B 137 THR B 138 0 SHEET 2 E 3 LEU B 187 ASP B 190 -1 O LEU B 189 N GLU B 137 SHEET 3 E 3 VAL B 195 LEU B 198 -1 O LYS B 197 N LEU B 188 SHEET 1 F 2 ILE B 177 CYS B 178 0 SHEET 2 F 2 LYS B 205 GLN B 206 -1 O LYS B 205 N CYS B 178

SITE 1 AC1 8 ILE A 62 ALA A 83 ASP A 133 TYR A 134 SITE 2 AC1 8 VAL A 135 PRO A 136 ARG A 141 LEU A 188 SITE 1 AC2 8 ILE B 62 ALA B 83 ASP B 133 TYR B 134 SITE 2 AC2 8 VAL B 135 PRO B 136 ARG B 141 LEU B 188

CRYST1 83.438 86.443 178.825 90.00 90.00 90.00 P 21 21 21 8

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.011985 0.000000 0.000000 0.00000

SCALE2 0.000000 0.011568 0.000000 0.00000

SCALE3 0.000000 0.000000 0.005592 0.00000